| Events

Upcoming events featuring our firm, its associates, and its partners.

Dodd-Frank and Non-Financial Companies

December 14th, 2010

Wall Street Reform: What Dodd-Frank means to Non-Financial Companies

Association of Corporate Counsel
When: December 16, 2010
Time: 8:00AM – 10:00AM
Where: Marriott Cleveland Hotel (2nd Floor)
www.acc.com

Speakers
Michele L. Connell, Cipriano S. Beredo III, David A. Zagore, Squire Sanders & Dempsey; Taras G. Szmagala, Senior Vice President and Chief Counsel, Industrial Sector, Eaton Corporation

Sponsors
NEOACCA, Squire Sanders, BOWNE of Cleveland

CLE Credit Available
Credits: 1.5 requested
State: Ohio
Category: general

RSVP Required
Register online at ACC Northeast Ohio Chapter

CFO Workshop

December 8th, 2010

Association for Corporate Growth

ACG: Cleveland
What: Event Workshop
When: December 09, 2010
Time: 3:00PM – 7:00PM
www.acg.org/cleveland

Join ACG Cleveland and seasoned Northeast Ohio company CFO’s as they discuss the challenges, opportunities, financial outlook, access to capital, cost of capital, impact from recent elections, healthcare, tax changes – learn what keeps them awake at night.

RSVP Required
Register online at www.acg.org/cleveland

Venture Capital: Moving Forward

December 8th, 2010

2020 Vision:
Venture Investment Opportunities for the Next Ten Years

Ohio Venture Capital Association
Speaker: Frank Douglas, President & CEO, Akron BioInnovation Institute
When: December 10, 2010
Time: 11:30AM – 1:30PM
www.ohioventure.org

Frank Douglas, former founder and executive director of Massachusetts Institute of Technology’s (MIT) Center of Biomedical Innovation, is an award-winning industry veteran with more than 24 years of experience in healthcare, pharmaceutical research, and biotechnology.

Douglas joins the BioInnovation Institute in Akron after serving as senior fellow, Ewing M. Kauffman Foundation; senior partner, Puretech Ventures; and chief scientific advisor, Bayer Healthcare, AG. Prior to that he served as professor of the Practice at MIT Schools of Management, Engineering, and Science and the Harvard-MIT Division of Health Sciences and Technology, an interdisciplinary educational and research program.

“The BioInnovation Institute in Akron represents a best-in-class model for the future of healthcare delivery and innovation,” said Douglas. “The history of the city of Akron, combined with outstanding contributions from each of the founding partners, has created a bedrock for excellence in the field of bioinnovation and I look forward to being part of this exceptional team.”

The BioInnovation Institute in Akron is transforming Akron into a model for biomedical discovery and enterprise. Together, the five operating founders of the Institute – Akron Children’s Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM), Summa Health System and The University of Akron – have a world-class reputation in research, education and health. Funding to create the BioInnovation Institute in Akron began with a grant from the John S. and James L. Knight Foundation, lead funder and founding partner of the Institute. The State of Ohio joined the founding members as a key partner in the development of the Institute from concept to reality. Through the collaboration of these complementary institutions, the goal of this initiative is to expand Akron’s rich legacy in materials science to pioneer the next generation of life-enhancing and life-saving innovation for the 21st Century.

Schedule

December 10, 2010
11:30 – 1:30
The Union Club
1211 Euclid Ave.
Cleveland, Ohio

RSVP Required
Register online at www.ohioventure.org